Feb 28, 2023

Featuring a slide presentation and related discussion from Dr Mrinal Gounder, including the following topics:

•      Efficacy and tolerability of sorafenib in patients with advanced and refractory desmoid tumors (00:00)

•      DESMOPAZ: Results of a Phase II trial of pazopanib versus IV methotrexate/vinblastine...

Feb 28, 2023

Featuring perspectives from Dr Mrinal Gounder, including the following topics:

•      Incidence and prevalence of desmoid tumors (00:00)

•      Outcomes associated with historical management paradigms for desmoid tumors (17:15)

•      Rationale for targeting the gamma secretase complex and Notch pathway as...

Feb 24, 2023

Featuring perspectives from Dr Komal Jhaveri, including the following topics:

•      Case: A premenopausal woman in her early 40s with a 5.8-cm, ER/PR-positive, HER2-negative infiltrating lobular carcinoma and microscopic sentinel node involvement — Arielle Heeke, MD (11:58)

•      Case: A premenopausal woman in...

Feb 23, 2023

Featuring perspectives from Drs Farrukh Awan and Kelly Rogers, including the following topics:

•      Case: A woman in her early 90s with underlying chronic obstructive pulmonary disease was observed for 20 years for chronic lymphocytic leukemia (CLL) before initiating treatment with acalabrutinib and quickly...

Feb 22, 2023

Featuring perspectives from Drs Tanios Bekaii-Saab, Scott Kopetz, and John Strickler and Prof Eric Van Cutsem, moderated by Dr Kristen Ciombor, including the following topics:

•      Integration of Therapies Targeting BRAF and HER2 in Metastatic Colorectal Cancer (mCRC) — Dr Strickler

o   Introduction (0:00)

o  ...